| |
| |
|
| Insider
Information: |
Palmer Ashleigh |
| Relationship: |
Director and CEO |
| City: |
Boonton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
50,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
50,000 |
|
|
| Total
Value |
$15 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -47.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Unigene Laboratories Inc |
UGNEQ |
President & CEO, Direc... |
2010-09-20 |
50,000 |
2010-06-18 |
0 |
Premium* |
|
|
Provention Bio Inc |
PRVB |
Director and CEO |
2023-04-27 |
0 |
2018-07-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRVB |
Provention Bio Inc |
Director and CEO |
• – – |
2023-04-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,570,050) |
0 |
0 |
- |
|
| PRVB |
Provention Bio Inc |
Director and CEO |
• • – |
2023-02-13 |
4 |
AS |
$10.04 |
$259,448 |
D/D |
(25,835) |
2,570,050 |
0 |
% |
|
| PRVB |
Provention Bio Inc |
Director and CEO |
• • – |
2023-02-13 |
4 |
OE |
$2.50 |
$64,588 |
D/D |
25,835 |
2,595,885 |
0 |
- |
|
| PRVB |
Provention Bio Inc |
Director and CEO |
• • – |
2023-02-10 |
4 |
AS |
$10.11 |
$505,555 |
D/D |
(50,000) |
2,570,050 |
0 |
% |
|
| PRVB |
Provention Bio Inc |
Director and CEO |
• • – |
2023-02-10 |
4 |
OE |
$2.50 |
$125,000 |
D/D |
50,000 |
2,620,050 |
0 |
- |
|
| PRVB |
Provention Bio Inc |
Director and CEO |
• • – |
2023-01-18 |
4 |
AS |
$10.27 |
$248,063 |
D/D |
(24,165) |
2,570,050 |
0 |
% |
|
| PRVB |
Provention Bio Inc |
Director and CEO |
• • – |
2023-01-18 |
4 |
OE |
$2.50 |
$60,413 |
D/D |
24,165 |
2,594,215 |
0 |
- |
|
| PRVB |
Provention Bio Inc |
President and CEO |
• • – |
2020-08-18 |
4 |
B |
$12.69 |
$6,345 |
D/D |
500 |
2,566,300 |
2.81 |
% |
|
| PRVB |
Provention Bio Inc |
President and CEO |
• • – |
2020-08-17 |
4 |
B |
$12.83 |
$35,924 |
D/D |
2,800 |
2,565,800 |
2.81 |
% |
|
| PRVB |
Provention Bio Inc |
President and CEO |
• • – |
2019-12-20 |
4 |
B |
$11.39 |
$23,634 |
D/D |
2,075 |
2,563,000 |
2.81 |
- |
|
| PRVB |
Provention Bio Inc |
President and CEO |
• • – |
2019-09-24 |
4 |
B |
$8.38 |
$25,140 |
D/D |
3,000 |
2,560,925 |
2.81 |
- |
|
| PRVB |
Provention Bio Inc |
President and CEO |
• • – |
2019-08-08 |
4 |
B |
$9.15 |
$96,990 |
D/D |
10,600 |
2,557,925 |
2.81 |
- |
|
| PRVB |
Provention Bio Inc |
President and CEO |
• • – |
2019-06-18 |
4 |
B |
$10.83 |
$43,320 |
D/D |
4,000 |
2,547,325 |
2.81 |
- |
|
| PRVB |
Provention Bio Inc |
President and CEO |
• • – |
2018-12-31 |
4 |
B |
$1.58 |
$1,304 |
D/D |
825 |
2,543,325 |
2.73 |
- |
|
| PRVB |
Provention Bio Inc |
President and CEO |
• • – |
2018-12-28 |
4 |
B |
$1.73 |
$8,650 |
D/D |
5,000 |
2,542,500 |
2.81 |
- |
|
| PRVB |
Provention Bio Inc |
President and CEO |
• • • |
2018-07-19 |
4 |
B |
$4.00 |
$150,000 |
D/D |
37,500 |
2,537,500 |
3.23 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
President & CEO |
• • – |
2010-09-20 |
4 |
B |
$0.70 |
$6,160 |
D/D |
8,800 |
50,000 |
2.81 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
President & CEO |
• • – |
2010-08-12 |
4 |
B |
$0.60 |
$12,000 |
D/D |
20,000 |
41,200 |
2.81 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
President & CEO |
• • – |
2010-06-18 |
4 |
B |
$0.77 |
$16,885 |
D/D |
21,200 |
21,200 |
2.81 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
